胡培丽，郑济凡，刘师卜，等.利清颗粒辅助降低大鼠血尿酸作用及安全性研究［J］.上海预防医学，2023，35（12）：1253-1257.. doi: 10.19428/j.cnki.sjpm.2023.23089
引用本文: 胡培丽，郑济凡，刘师卜，等.利清颗粒辅助降低大鼠血尿酸作用及安全性研究［J］.上海预防医学，2023，35（12）：1253-1257.. doi: 10.19428/j.cnki.sjpm.2023.23089
shu
HU Peili,ZHENG Jifan,LIU Shibo,et al.Effect and safety of Liqing granules in assisting to reduce serum uric acid in rats[J].Shanghai Journal of Preventive Medicine,2023,35(12):1253-1258.. doi: 10.19428/j.cnki.sjpm.2023.23089
Citation: HU Peili,ZHENG Jifan,LIU Shibo,et al.Effect and safety of Liqing granules in assisting to reduce serum uric acid in rats[J].Shanghai Journal of Preventive Medicine,2023,35(12):1253-1258.. doi: 10.19428/j.cnki.sjpm.2023.23089
shu

利清颗粒辅助降低大鼠血尿酸作用及安全性研究

Effect and safety of Liqing granules in assisting to reduce serum uric acid in rats

    摘要
  • 摘要:
    目的 建立高尿酸血症（HUA）大鼠模型，研究利清颗粒辅助降血尿酸作用并对其安全性进行评价。
    方法 将雄性SD大鼠按体重随机分为溶剂对照组和模型组，模型组灌胃氧嗪酸钾造模7 d后检测血清尿酸（SUA）。根据SUA水平随机分为模型对照组、阳性对照组和低中高剂量组。模型组各组上午继续灌胃氧嗪酸钾，下午分别给予0.5%羧甲基纤维素钠（CMC⁃Na）、10 mg·kg-1苯溴马隆（按体重计）和利清颗粒0.6、1.2、2.4 g·kg-1（按体重计）。溶剂对照组上、下午均给予同体积0.5% CMC⁃Na混悬液。给予受试物32、45 d后，检测大鼠SUA、肌酐（CREA）、丙氨酸氨基转移酶（ALT）和天冬氨酸氨基转移酶（AST）水平。
    结果 模型组造模7 d后SUA为（218±23） μmol·L-1，较溶剂对照组显著升高（P<0.001）。给予受试物32 d后各剂量组SUA未见降低（P>0.05）；中、高剂量组CREA显著降低（P<0.05）。给予受试物45 d后各剂量组SUA均显著降低（P<0.01），CREA、ALT及AST较模型对照组差异均无统计学意义（P>0.05）。
    结论 利清颗粒对HUA模型大鼠具有辅助降血尿酸作用，未见相关肝肾功能损伤。

     

    Abstract:
    Objective To establish a rat model of hyperuricemia （HUA）， to study the effect of Liqing granules on lowering serum uric acid， and to evaluate its safety.
    Methods Male SD rats were randomly divided into solvent control group and model group according to their body weight. For the model group， serum uric acid （SUA） was determined after 7 days of intra-gastric administration of potassium oxyazinate. The model group were randomly divided into model control group， positive control group， and low， medium， high dose group based on SUA level. Each group from the model group continued to receive potassium oxyazinate in the morning. The animals in the model groups received 0.5% CMC-Na， 10 mg·kg-1 benzbromarone （Doses by body weight） and Liqing granules 0.6， 1.2， 2.4 g·kg-1 （Doses by body weight）， respectively in the afternoon. 0.5% CMC-Na suspension with the same volume was given both in the morning and afternoon for the solvent control group. Levels of SUA， creatinine （CREA）， alanine aminotransferase （ALT） and aspartate transaminase （AST） were determined after 32 and 45 days administration of the test substance.
    Results SUA of the model group was （218±23） μmol·L-1 after 7 days of modeling， which was significantly higher than that of the solvent control group （P<0.001）. After 32 days administration of the test substance， SUA didn’t significantly decrease in each dose group （P>0.05）. CREA in the medium and high dose groups significantly decreased （P<0.05）. After 45 days administration of the test substance， SUA in each dose group was significantly decreased （P<0.001）， but CREA， ALT， and AST were not significantly different in each dose group in comparison with the model control group （P>0.05）.
    Conclusion Liqing granules can assist in lowering blood serum uric acid in the rat HUA model， and no damage to liver and kidney function is found.

     

    • HTML全文
    • 参考文献(31)
    • 相关文章
    • 施引文献
  • 资源附件(0)

/

返回文章
返回